@twpainter

Anaesthetist. Clinical trials in anaesthesia and perioperative medicine.

 Adelaide, South Australia
Joined June 2009
  • Tweets352
  • Following405
  • Followers157
12Media
Replying to @twpainter
@twpainter live at #ASM22PER acknowledging the huge contribution of @ctn_anzca & @POISE3_ANZ to the #POISE3 trial. Thank you to all of the site contributors #whatateam! @gillyormo @katy_skier @ealmaxwell @davimcall @AlliKearney
1
7
1
10
Call out to all our NZ & Australian POISE-3 sites to tune into @twpainter presenting the TxA arm results of the POISE-3 trial shortly! Learn about the implications to patient care & safety! Thank you for your hard work and dedication! #ASM22PER @ANZCA @PHRIresearch @katy_skier
7
16
The results of the tranexamic acid (TxA) arm of the @POISE3_ANZ #RCT have been published in @NEJM. The trial definitely showed the benefits of using TxA in non-cardiac surgery patients. Read our press release: bit.ly/38xw8YP @ANZCA @PHRIresearch @twpainter @katy_skier
8
2
14
Translation of our results will be very important @POISE3_ANZ
Tumul Chowdhury (तुमुल चौधरी) MD, DM, FRCPC, MSc@ChowdhuryTumul3 Apr 2022
Replying to @david__highton @twpainter
All major surgical procedures do not lead to significant blood risks so need to choose TXA wisely (if bleeding risk is significant enough or microhemostasis is a problem etc.) These risks are multi factorial.
1
5
Congratulations to Prof Kate Leslie @katy_skier, Dr @twpainter, co-investigators & coordinators at sites across Australia and New Zealand who contributed to the first publication from the @nhmrc funded #POISE3 Trial @PHRIresearch @ctn_anzca @ANZCA @UniMelbMDHS @TheRMH @MischHub
NEJM
@NEJM2 Apr 2022
Among patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with placebo. #ACC22 nej.md/3IMTKoz
6
12
Tom Painter retweeted
NEJM
@NEJM2 Apr 2022
Among patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with placebo. #ACC22 nej.md/3IMTKoz
4
66
24
127
@POISE3_ANZ was only made possible due to the amazing the contribution of our dedicated @ctn_anzca sites. Thank you 🙏🏻 @NEJM @NHMRC @twpainter @katy_skier @ealmaxwellhard @PHRIresearch #ACC22 @AlliKearney @gillyormo @ACTAcommunity @CritCareUniMelb
2
1
4
Thank you to @katy_skier @twpainter @ealmaxwell for your incredible leadership to run @POISE3_ANZ in Australia and New Zealand. Thank you to @gillyormo @AlliKearney @davimcall for coordinating the trial. @ANZCA @CritCareUniMelb @NEJM @nhmrc @ACTAcommunity #ACC22 #CTN2022 @ANZCA
POISE-3 Australia and New Zealand@POISE3_ANZ2 Apr 2022
Replying to @POISE3_ANZ
@POISE3_ANZ was only made possible due to the amazing the contribution of our dedicated @ctn_anzca sites. Thank you 🙏🏻 @NEJM @NHMRC @twpainter @katy_skier @ealmaxwellhard @PHRIresearch #ACC22 @AlliKearney @gillyormo @ACTAcommunity @CritCareUniMelb
3
5
Tom Painter retweeted
Kate Leslie@katy_skier29 Aug 2021
Good question 🤔 @david__highton cogPOISE-3 randomizing patients to hypertension-avoidance or hypotension-avoidance should provide a definitive answer @POISE3_ANZ @twpainter @gillyormo @ctn_anzca @CritCareUniMelb @PHRIresearch – at Dinner Plain, Victoria
David Highton@david__highton29 Aug 2021
Replying to @lisbethevered @BJAJournals @ANZCA @WCMAnesthesia @katy_skier @scottdav44 @ASA_Australia @ASAMonitor
Outstanding work. Do you think it could potentially be the vasopressors rather than the volatile dose? Known to reduce cerebral oxygenation…. journals.lww.com/jnsa/Abstra…
2
4
Can I just point out that the car wasn’t driving itself? I think this is unfair to Ford Fairmonts.
1
2
A fabulous end to a great meeting @ctn21 @ctn_anzca @anzca. Thank you to all the wonderful people that have made this possible.
4
1
15
Replying to @POISE3_ANZ
@POISE3_ANZ
1
Cake wars
1
1
4
Tom Painter retweeted
Kate Leslie@katy_skier22 Jul 2021
A big thank you to the @ctn_anzca @anzca @david__highton who have re-jigged #CTN21 again 😬😅😇 Now a virtual meeting with Brisbane hub. Looking forward to more great RCTs! – at Melbourne, Victoria
ANZCA Clinical Trials Network@ctn_anzca31 May 2021
Registration & call for abstracts now open for the @ANZCA CTN workshop! Join us in sunny Brisbane for #CTN21 on 5-8 August 2021. Virtual and in-person registration options available. For more info and to register visit the website: bit.ly/3yI4wZr
1
4
9
That’s not a cake. THIS is a cake! 😃 (well done)
Tom Painter@twpainter7 Jul 2021
Replying to @twpainter
Hey @david__highton … I think may have outcaked you … 😂
2
2
10
The team! Fantastic work by the RAH team. 600 combined patients - what an amazing achievement- this deserves cake!! ⁦@ctn_anzca⁩ ⁦@ANZCA⁩
3
5
3
21
Hey @david__highton … I think may have outcaked you … 😂
3
1
2
5
200 now .... 😉🕺🏼💃. I am so fortunate to work with an incredible team!
POISE-3 Australia and New Zealand@POISE3_ANZ24 May 2021
Woo Hoo!!! Our team at the Royal Adelaide Hospital have recruited the 698th @POISE3_ANZ patient but also their 199th Patient at the site. Amazing effort by all involved. 🥳🥳@twpainter @JaseenH @SAHealth @ctn_anzca @ANZCA @PHRIresearch #anaesthesiaresearch #clinicaltrials
1
1
4
Tom Painter retweeted
David Scott@scottdav4420 May 2021
Celebrating International Clinical Trials day 2021 and the massive contribution that @ctn_anzca and @ANZCA has made and is making now! Most recently with the @PADDI_Trial, & now recruiting to the @ChewyTrial , #ROCKetTrial🚀 & @TrigsTrial! #CTN21 #CTD2021 anzca.edu.au/research/anzca-… – at Melbourne, Victoria

ANZCA Clinical Trials Network - ANZCA

We are the leading clinical trials network in anaesthesia, pain and perioperative medicine.

anzca.edu.au
1
6
19
Dexamethasone and Surgical-Site Infection | NEJM nejm.org/doi/pdf/10.1056/NEJ…
Load more